Moderna’s Cancer Factory Is the Real Story
A Phase 3 melanoma win proves mRNA oncology. Can it scale?
A Phase 3 melanoma win proves mRNA oncology. Can it scale?
September 18, 2026 Bonus Content: US Energy and Farm Goods Are the Real Trade at Stake A note from our…
Same-day availability on every configuration is a demand signal of the cycle, and it cuts both ways for Apple investors.
With the stock near $318 and 20 of 34 analysts rating it a Buy, the question is whether the AI threat is priced in or just getting started.
The war premium is unwinding, but Hormuz is still at 8 transits a day, versus a normal 85. How much farther crude can fall is the session’s central question.
September 17, 2026 Bonus Content: The S&P 500 Has 4.6% of Upside Left. That Changes How Much Risk You Should…
The Space Force’s first public admission of on-orbit weapons is less a geopolitical headline than a procurement signal, and the money trails point to specific names.
Empire State fell 13 points to 7.6, Japan’s machinery orders dipped again, and a hike is widely expected at 2 PM ET.
A note from our friends at Media Pub(ad) Most traders have never noticed the weird market anomaly that happens at…
SB Energy plans to sell up to $500 million of its IPO shares in Japan.